Ion Channels as Therapeutic Targets, Part A: Volume 103

Ion Channels as Therapeutic Targets, Part A: Volume 103

Series edited by 

Free delivery worldwide

Available. Dispatched from the UK in 2 business days
When will my order arrive?


Ion Channels as Therapeutic Targets is the latest volume in the popular Advances in Protein Chemistry and Structural Biology series, an essential resource for protein chemists. Each volume brings forth new information about protocols and analysis of proteins, with each thematically organized volume guest edited by leading experts in a broad range of protein-related topics.
show more

Product details

  • Hardback | 402 pages
  • 152 x 229 x 22.86mm | 820g
  • Academic Press Inc
  • San Diego, United States
  • English
  • 0128047941
  • 9780128047941

Table of contents

Proteostasis Maintenance of Cys-Loop Receptors
Yan-Lin Fu, Ya-Juan Wang and Ting-Wei Mu
Harnessing the Flow of Excitation: TRP, Voltage-Gated Na+, and Voltage-Gated Ca2+ Channels in Contemporary Medicine
Roman V. Frolov and Matti Weckstroem
Ion Channels in Neurological Disorders
Pravir Kumar, Dhiraj Kumar, Saurabh Kumar Jha, Niraj Kumar Jha and Rashmi K. Ambasta
Acid Sensing Ion Channels as Potential Pharmacological Targets in Peripheral and Central Nervous System Diseases
Beatrice Mihaela Radu, Adela Banciu, Daniel Dumitru Banciu and Mihai Radu
Glutamatergic NMDA Receptor as Therapeutic Target for Depression
Gislaine Z. Reus, Helena M. Abelaira, Talita Tuon, Stephanie E. Titus, Zuleide M. Ignacio, Ana Lucia S. Rodrigues and Joao Quevedo
AMPA Receptors as Therapeutic Targets for Neurological Disorders
Kevin Lee, Lucy Goodman, Chantelle Fourie, Susan Schenk, Beulah Leitch and Johanna M. Montgomery
pH-Sensitive K+ Currents and Properties of K2P Channels in Murine Hippocampal Astrocytes
Johannes Weller, Christian Steinhauser and Gerald Seifert
SUMOylation and Potassium Channels: Links to Epilepsy and Sudden Death
Hongmei Wu, Xu Chen, Jinke Cheng and Yitao Qi
show more

About Rossen Donev

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2010 Dr. Donev was appointed Lecturer in Swansea University. Currently he is Director of Biomed Consult Ltd, UK. His major research interests include signalling pathways involved in neuropsychiatric disorders and tumour escape from the immune system, and development of therapeutic strategies for treatment. He has published more than 50 research papers, has chaired scientific meetings in Molecular Medicine and given plenary talks at Attention Deficit/Hyperactivity Disorder meetings. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals.
show more